Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Miwa Kawakubo"'
Autor:
Ellen F. Binder, Chris J. Hahn, Matthew D. Dunn, Ronenn Roubenoff, Miwa Kawakubo, Fred R. Sattler, Carmen Martinez, E. Todd Schroeder, Carmen Castaneda-Sceppa, Yolanda Stewart, Stanley P. Azen, Shalender Bhasin, Kevin E. Yarasheski, Jiaxiu He
Publikováno v:
Clinical Endocrinology. 75:103-111
Summary Objectives To determine the durability of anabolic effects and adverse events (AEs) after stopping testosterone and growth hormone supplementation in older men. Design Secondary analysis of a double-masked, randomized controlled trial of test
Autor:
Shalender Bhasin, Carmen Castaneda-Sceppa, Jiaxiu He, Stanley P. Azen, Anqi Zhang, Kevin E. Yarasheski, Miwa Kawakubo, Fred R. Sattler, Chih-Ping Chou, Ronenn Roubenoff, E. Todd Schroeder, Ellen F. Binder
Publikováno v:
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. :122-129
LOSS of skeletal muscle mass (sarcopenia) contributes to declines in muscle performance and physical function during aging. Substantial losses in muscle strength may result in difficulty rising from a chair, climbing stairs, generating gait speed, ma
Publikováno v:
Diabetes Care
OBJECTIVE To identify factors associated with declining β-cell compensation for insulin resistance. RESEARCH DESIGN AND METHODS In a cohort of Hispanic women with recent gestational diabetes mellitus, oral glucose tolerance tests (OGTTs), intravenou
Autor:
Jean M. Lawrence, Richard M. Watanabe, Lori L. Bonnycastle, Thomas A. Buchanan, Xia Li, Hooman Allayee, Markku Laakso, Heather M. Stringham, Miwa Kawakubo, Yu-Hsiang Shu, Jaana Hartiala, Johanna Kuusisto, Anny H. Xiang, Enrique Trigo, Amy J. Swift
Publikováno v:
Diabetes
OBJECTIVE Glucokinase (GCK) and glucose-6-phosphatase catalytic subunit 2 (G6PC2) regulate the glucose-cycling step in pancreatic β-cells and may regulate insulin secretion. GCK rs1799884 and G6PC2 rs560887 have been independently associated with fa
Autor:
Aura Marroquin, Miwa Kawakubo, Thomas A. Buchanan, Anny H. Xiang, Howard N. Hodis, Chao-ran Liu, Siri L. Kjos, Ruth K. Peters, Cesar Ochoa, Ci-hua Liu, Jose Goico
Publikováno v:
Atherosclerosis. 199:207-214
The Pioglitazone in the Prevention of Diabetes (PIPOD) study was a single arm 3-year open-label pioglitazone treatment to determine the effects of pioglitazone in women with prior gestational diabetes mellitus (GDM) who had completed the troglitazone
Publikováno v:
Diabetes Care. 30:1952-1958
OBJECTIVE—To investigate the effect of nonhormonal contraception (NHC), combination oral contraception (COC), and depo-medroxyprogesterone acetate (DMPA) on lipids and blood pressure in women with recent gestational diabetes mellitus (GDM). RESEARC
Autor:
Stanley P. Azen, Susan Coomber, Nicole E. Jensky, Carmen Castaneda-Sceppa, Ying Wang, Gregory J. Cloutier, Miwa Kawakubo, Fred R. Sattler, E. Todd Schroeder, Alberto F. Vallejo
Publikováno v:
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 62:543-549
Background. Maximal voluntary muscle strength (MVMS) and leg power are important measures of physical function in older adults. We hypothesized that performing these measures twice within 7–10 days would demonstrate a .5% increase due to learning a
Publikováno v:
Diabetes Care. 29:613-617
OBJECTIVE—To investigate the impact of a long-acting injectable progestin, depo-medroxyprogesterone acetate (DMPA), compared with combination oral contraceptives (COCs) on the risk of diabetes in Latino women with prior gestational diabetes mellitu
Autor:
Siri L. Kjos, Jose Goico, Cesar Ochoa, Anny H. Xiang, Thomas A. Buchanan, Miwa Kawakubo, Aura Marroquin, Ruth Peters
Publikováno v:
Diabetes. 55:517-522
The Pioglitazone In Prevention Of Diabetes (PIPOD) study was conducted to evaluate beta-cell function, insulin resistance, and the incidence of diabetes during treatment with pioglitazone in Hispanic women with prior gestational diabetes who had comp
Publikováno v:
The American Journal of Cardiology. 94:431-436
Tracking of coronary artery calcium (CAC) has been suggested for monitoring the effects of lipid control, but it is not known whether lipid control decreases progression of CAC. Seven hundred sixty-one subjects (mean age 64.5 +/- 7.3 years; 91% men;